We explore the possibilities and potential of complementary and alternative medicine with the aim of making it available to everyone. The focus is currently on homeopathy. To this end, we develop research concepts, award research contracts, publish relevant results and train specialist groups. As soon as there is sufficient reliable data, we will support the implementation of these therapy methods in Germany and abroad.

CAM is short for "Complementary and Alternative Medicine". Pace has several meanings: It stands for patient-centered, which means that we align our research to the needs of patients. Our goal is to research and further develop the potential of complementary methods, whereby the specific applicability is always in focus. Pace means "tempo" in English. We apply systematic and innovative research methods. We draw on a broad, international network of partners who share our vision. They support us with their knowledge and are at the same time multipliers of our work. This network enables us to act quickly and, above all, flexibly. And we are concerned with a peaceful approach that does not require animal testing and is not competitive (pace lat.= in peace).

We wish for a fairer medicine. We want everyone to have access to effective therapies, regardless of their economic, social or regional background. We are united by fundamental values and thoughts, such as the belief in people working together, the knowledge of what CAM can do for the benefit of patients and the idea of effective, safe and sustainable open source medicine.We research using the latest technologies and an inspired spirit of inquiry to make this a reality.

We are a Team made up of women and men who bring very different professional expertise to the table. In detail: Gregor Kindelmann is the founder and managing director of Campace, he organizes the scientific network and develops the research system.Karen Schürmann has taken over the management of the office and is making a significant contribution to the development of Campace's structures.Jeremy Sherr contributes his many years of practical experience and drug provings. Jörg Wichmann has taken over the registration of all homeopathic individual remedies. Elisabeth von Wedel will support us in developing implementation strategies. Christine Lauterbach is responsible for the training concept.Through our cooperation with other research institutions, we work together with various scientists from the field of biotechnology. Otherwise, our network includes many therapists working in complementary and alternative medicine, donors and interested parties who contribute their specific knowledge, build structures and keep them running. And our organization is constantly growing, because this is the only way to implement a project of this scope.

On the one hand, Campace has share capital in order to initially set up the necessary structures. Some of the tests that are currently being carried out are financed by a research assignment from Michael Gracher from GSE sales, who shows great commitment to various aid projects. We will be able to implement the next steps, which will enable us to work even more systematically and comprehensively, through donations and grants.

The basic effect of homeopathic remedies has been proven in clinical studies as well as in animal and plant models. Most of the systematic reviews, which are the strongest criterion in evidence-based medicine, show effects that go beyond the placebo effect.In addition, there are already many studies for homeopathy from a wide variety of scientific research fields: Jean-Louis Demangeat and Steven J. Cartwright show physical effects of potentized substances, Luc Montaginers determines biological effects. Other research series demonstrate statistically highly significant effects in plant models, e.g. with duckweed or wheatgrass. Last but not least, healthcare research shows that homeopathic treatments are effective.The treatment successes of homeopaths who have specialized in the treatment of serious illnesses such as cancer suggest a closer look at homeopathy in this context.The relatively low costs and the robustness of the medicines - they are heat and cold stable and can be administered orally - also make this medicine a good alternative in low-income and structurally weak regions.

That would be too convenient. Of course, practitioners and patients do not need proof, but our research aims to improve the method and make it accessible to a larger number of patients. Through the use of modern research methods, we will be able to make great leaps in knowledge and thus gain access to medicines that have not been used up to now. Apart from that, according to the Forsa study, 75% of those questioned would like homeopathy to be researched. 50-60% of Germans use homeopathic medicines. This group has the right to conduct research in this area in order to ultimately make an informed and informed decision.

We are fully focused on human applications. We want to expand and improve treatment options. Additional evidence that homeopathy cannot be reduced to placebo effects will only be a by-product. We are concerned with fair and just medicine to which everyone has access, and with the scientific participation of all those who consider research in this area to be important. In addition, we want patients and therapists to be able to make an informed decision.

Many problems of our time can only be solved globally. That's why our network of employees and supporters is international, and what we do aims to improve health care, particularly in low-income and structurally weak regions.

The way Campace works is to develop research concepts and then award research contracts to specialized institutions or scientists. The results are made freely accessible to the professional public and, where necessary, special training courses are offered. Furthermore, we support the implementation of the results within the framework of aid projects at home and abroad, e.g. by providing medicines or diagnostic equipment and training employees.

Definitely. The WHO "Traditional Medicine Strategy 2014-2023" concludes, among other things, that qualified complementary medicine can make a positive contribution to general health protection. It is also pointed out that CAM procedures have the potential to reduce healthcare costs. Against the background of the increase in chronic diseases, the recommendation should also be to work towards improved cooperation between the conventional and alternative health sectors.

There are different reasons for this procedure. On the one hand we have very encouraging results regarding the treatment of cancer patients, e.g. from Jens Wurster in Italy, the Banerji Foundation in India and several clinics in the USA as well as from many other experienced therapists worldwide. On the other hand, there are many people who have not had access to effective cancer therapies due to their socio-economic situation.In drug research, there are meaningful, cell-based in vitro experiments with which the effects of a wide variety of substances on cancer cells can be examined. These are processes that have become indispensable in scientific work. We use these to identify potentially helpful homeopathic medicines and then subject them to further testing.

The most important question is which drugs, apart from those already known, can have an inhibiting effect on the growth of cancer cells or activate the patient's immune system to better recognize and fight cancer cells. Furthermore, we want to get hints as to which dose or dosage brings the best results.

Resistance development is an issue of immense importance. Therefore, we should use all possibilities to prevent them from occurring, including the use of homeopathy and other CAM methods.The manufacturing processes of conventional medicines can have a high environmental impact, especially in countries with lax environmental regulations. But some excretions of medicines or the corresponding degradation products also pollute the waters.Such effects are not to be expected from homeopathic medicines, since they have no toxic effects in higher potencies - they are therefore harmless for the patient and the environment. Against this background, it is also logical that animal experiments can be dispensed with in homeopathy research. Homeopathic manufacturing processes are also more sustainable in terms of CO2 emissions and the preservation of biodiversity.